No Data
No Data
Hang Seng Index: Benefiting from policy support, biotechnology stocks have seen three consecutive months of inflows.
The Hang Seng Index company stated that there are signs of improvement in the recent situation of biotechnology stocks, as well as benefitting from policy support and three consecutive months of inflow of funds.
WuXi AppTec-B (02126.HK) appointed Liu Min as Executive President and Executive Director.
On July 31, Gelonghui -B (02126.HK) announced that Mr. Liu Min has been appointed as the company's Executive President and Executive Director, effective from July 31, 2024. Mr. Liu will lead the group, focusing on innovation, strategic cooperation, excellent operation, and creating long-term value for all stakeholders. Dr. Yiping James Li, the company's Executive Director and Chief Executive Officer, resigned as the company's Executive Director due to his desire to devote more time to his family and other personal interests, effective July 31, 2024. The Board of Directors has reappointed Dr. Li as a non-executive director.
Express News | JW (Cayman) Therapeutics - Yiping James Li an Executive Director and CEO Resigned as Chief Executive Officer
Express News | JW (Cayman) Therapeutics - Min Liu Appointed as CEO of Company and as Executive Director
JW (Cayman) Therapeutics Co. Ltd's (HKG:2126) Shares Leap 26% Yet They're Still Not Telling The Full Story
Changes in Hong Kong stocks | Pharmaceutical Juno-B (02126) rose more than 8%, SLE clinical data showed good safety
Pharmaceutical Juno-B (02126) rose more than 8%. As of press release, it had risen 8.29% to HK$2.35, with a turnover of HK$2,041,800.
No Data